High-Grade Serous Fallopian Tube Cancer

About

Mappings

NCI Thesaurus: Fallopian Tube High Grade Serous Adenocarcinoma (coding:ncit:C126456)

OncoTree: High-Grade Serous Fallopian Tube Cancer (coding:oncotree:HGSFT)

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations	Biomarkers	Cancer types	Therapies
FDA (2)	BRCA1 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Niraparib
FDA (2)	BRCA2 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Niraparib
EMA (1) FDA (4)	BRCA1 oncogenic variants	High-Grade Serous Fallopian Tube Cancer	Olaparib
EMA (1) FDA (4)	BRCA1 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Olaparib
EMA (1) FDA (4)	BRCA2 oncogenic variants	High-Grade Serous Fallopian Tube Cancer	Olaparib
EMA (1) FDA (4)	BRCA2 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Olaparib
EMA (1) FDA (2)	BRCA1 oncogenic variants	High-Grade Serous Fallopian Tube Cancer	Bevacizumab, Olaparib
EMA (1) FDA (2)	BRCA1 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Bevacizumab, Olaparib
EMA (1) FDA (2)	BRCA2 oncogenic variants	High-Grade Serous Fallopian Tube Cancer	Bevacizumab, Olaparib
EMA (1) FDA (2)	BRCA2 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Bevacizumab, Olaparib
EMA (1) FDA (2)	HRD	High-Grade Serous Fallopian Tube Cancer	Bevacizumab, Olaparib
FDA (2)	BRCA1 oncogenic variants	High-Grade Serous Fallopian Tube Cancer	Rucaparib
FDA (2)	BRCA1 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Rucaparib
FDA (2)	BRCA2 oncogenic variants	High-Grade Serous Fallopian Tube Cancer	Rucaparib
FDA (2)	BRCA2 pathogenic variants	High-Grade Serous Fallopian Tube Cancer	Rucaparib
EMA (1) FDA (2)	FOLR1 positive	High-Grade Serous Fallopian Tube Cancer	Mirvetuximab soravtansine
EMA (1) FDA (2)	PD-L1 (CPS) >= 1	High-Grade Serous Fallopian Tube Cancer	Paclitaxel, Pembrolizumab
EMA (1) FDA (2)	PD-L1 (CPS) >= 1	High-Grade Serous Fallopian Tube Cancer	Bevacizumab, Paclitaxel, Pembrolizumab